The evaluation of two genetic polymorphisms of paraoxonase 1 in patients with pulmonary embolism
- PMID: 29682786
- PMCID: PMC6817192
- DOI: 10.1002/jcla.22455
The evaluation of two genetic polymorphisms of paraoxonase 1 in patients with pulmonary embolism
Abstract
Background and objective: Pulmonary embolism (PE) is caused by some genetic factors for more than half patients. Paraoxonase 1 (PON1) has significant anti-oxidative and anti-inflammatory effects. According to our knowledge, there is no study researching the relation between PON 1 gene polymorphisms and PE in the literature. Therefore, it is aimed to research possible impacts of PON 1 Q192R and L55M polymorphisms on PE, considering anti-inflammatory and anti-oxidative effects of PON 1 in Turkish population.
Methods: One hundred and five PE patients and one hundred and seventeen controls were enrolled in this study. Genomic DNA was isolated and genotyped using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) analyses for the PON1 gene Q192R and L55M polymorphisms.
Results: Any associations were not found between clinical and demographical characteristics of PE patients and the PON1 gene Q192R polymorphism; however, there were associations between surgery, chronic renal failure, and cerebrovascular disease on the history of patients and L55M polymorphism (P = .013, P = .037, and P = .031, respectively). Genotype and allele frequencies did not show any significant differences between patients and controls according to PON1 gene Q192R and L55M polymorphisms (P > .05).
Conclusion: The results of this study suggest that there is no correlation between PE and PON 1 gene Q192R and L55M polymorphisms in the Turkish population from the Central Black Sea region. Besides, whole genotypes and alleles of Q192R and L55M are not risk factors for patients with PE in this population.
Keywords: L55M; PON1; Q192R; polymorphism; pulmonary embolism.
© 2018 Wiley Periodicals, Inc.
Similar articles
-
Association of paraoxonase-1(Q192R and L55M) gene polymorphisms and activity with colorectal cancer and effect of surgical intervention.Asian Pac J Cancer Prev. 2015;16(2):803-9. doi: 10.7314/apjcp.2015.16.2.803. Asian Pac J Cancer Prev. 2015. PMID: 25684529
-
Association of paraoxonase 1 (PON1) L55M and PON1 Q192R gene polymorphisms and risk of psoriasis.G Ital Dermatol Venereol. 2019 Jun;154(3):321-326. doi: 10.23736/S0392-0488.17.05514-6. Epub 2017 Apr 11. G Ital Dermatol Venereol. 2019. PMID: 28399619
-
Paraoxonase 1 (PON1) L55M and Q192R polymorphisms are not associated with chronic kidney disease in Thai individuals with type 2 diabetes.Int J Clin Pract. 2021 Dec;75(12):e14982. doi: 10.1111/ijcp.14982. Epub 2021 Oct 20. Int J Clin Pract. 2021. PMID: 34637171
-
Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity: A meta-analysis.Z Gerontol Geriatr. 2016 Jan;49(1):24-31. doi: 10.1007/s00391-015-0892-1. Epub 2015 May 12. Z Gerontol Geriatr. 2016. PMID: 25962362 Review.
-
Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis.Neurol Sci. 2015 Jan;36(1):11-20. doi: 10.1007/s10072-014-1979-y. Epub 2014 Oct 10. Neurol Sci. 2015. PMID: 25301263 Review.
References
-
- Basol N, Karakus N, Savas AY, Kaya I, Karakus K, Yigit S. The importance of MTHFR C677T/A1298C combined polymorphisms in pulmonary embolism in Turkish population. Medicina (Kaunas). 2016;52:35‐40. - PubMed
-
- Meyer G. Effective diagnosis and treatment of pulmonary embolism: improving patient outcomes. Arch Cardiovasc Dis. 2014;107:406‐414. - PubMed
-
- Lucassen W, Geersing GJ, Erkens PM, et al. Clinical decision rules for excluding pulmonary embolism: a meta‐analysis. Ann Intern Med. 2011;155:448‐460. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous